Evidence map›Paper›PMID 35095805›Full record

ArticleFrontiers in microbiology2021

The Role of

Ryuichi Nakano, Yuki Yamada, Akiyo Nakano, Yuki Suzuki, Kai Saito, Ryuji Sakata, Miho Ogawa, Kazuya Narita, Akio Kuga, Akira Suwabe and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Unique Regulation of Sed-1 β-Lactamase inAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ryuichi NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
Yuki YamadaDivision of Central Clinical Laboratory, Iwate Medical University Hospital, Yahaba, Japan.
Akiyo NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
Yuki SuzukiDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
Kai SaitoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
Ryuji SakataDepartment of Bacteriology, BML Inc., Kawagoe, Japan.
Miho OgawaDepartment of Bacteriology, BML Inc., Kawagoe, Japan.
Kazuya NaritaDivision of Central Clinical Laboratory, Iwate Medical University Hospital, Yahaba, Japan.
Akio KugaHamamatsu Pharmaceutical Association, Hamamatsu, Japan.
Akira SuwabeDepartment of Laboratory Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.
Hisakazu YanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
Nara Medical University · JPIwate Medical University · JPHamamatsu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various carbapenemases have been identified in the Enterobacteriaceae. However, the induction and corresponding regulator genes of carbapenemase NmcA has rarely been detected in the

Indexed as

AmpC β-lactamasecarbapenemaseEnterobacter cloacae complexinductionNmcAregulator genes

Identifiers

PMID35095805
PMCPMC8790168
OpenAlexW4206083035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.